Protemix Corporation Limited

Protemix is a biopharmaceutical company dedicated to the discovery, development and commercialisation of novel treatments for cardiovascular disease, diabetes mellitus and other metabolic disorders and diseases.Protemix has developed an exciting pipeline of diabetes-related drugs, including one compound, Laszarin™, currently undergoing Phase IIb clinical trials and a number of promising pre-clinical drug candidates

Contact Details: Level 28 IAG House151 Queen Street PO Box 2165 Auckland New Zealand Tel: 64 9 303 5350 Fax: 64 9 303 5359 Email: info@protemix.com WWW: www.protemix.co.nz/

Protemix Corporation Limited Patents:
US Patent No.	Title
7582796	Synthesis of triethylenetetramines
7365170	Adiponectin and uses thereof
6951890	Preventing and/or treating cardiovascular disease and/or associated heart failure
6897243	Fructosamine oxidase: antagonists and inhibitors
6884575	Phosphoprotein target for insulin and its antagonists
→View more Protemix Corporation Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 310 times since April 2007, the link to the organisation's website has been followed 43 times

Recent Search Terms used to find this page: protemix | protemix corporation | .

Search for more companies in Auckland

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protemix Corporation Limited